PolyPeptide Group AG (XSWX:PPGN) Long-Term Capital Lease Obligation : CHF17.8 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Long-Term Capital Lease Obligation?

PolyPeptide Group AG's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF17.8 Mil.

PolyPeptide Group AG's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (CHF17.4 Mil) to Jun. 2023 (CHF19.0 Mil) but then declined from Jun. 2023 (CHF19.0 Mil) to Dec. 2023 (CHF17.8 Mil).

PolyPeptide Group AG's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (CHF15.6 Mil) to Dec. 2022 (CHF17.4 Mil) and increased from Dec. 2022 (CHF17.4 Mil) to Dec. 2023 (CHF17.8 Mil).

PolyPeptide Group AG Long-Term Capital Lease Obligation Historical Data

The historical data trend for PolyPeptide Group AG's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Long-Term Capital Lease Obligation Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

9.68

11.30

15.56

17.42

17.80

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial					15.56	16.98	17.42	19.03	17.80

PolyPeptide Group AG (XSWX:PPGN) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

PolyPeptide Group AG Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines